April 18th, 2013
Advice for Physicians: How to Behave Online
Larry Husten, PHD
Although the internet represents “a new frontier in medicine” for physicians and patients, it also presents numerous and novel challenges to professionalism, according to a position paper from the American College of Physicians and the Federation of State Medical Boards published in the Annals of Internal Medicine.
The paper offers physicians a new conceptual “framework for analyzing medical ethics and professionalism issues” on the internet and provides recommendations for physicians on the use of email, blogs, social media sites, and more.
Although there are numerous valuable educational resources available, the authors advise physicians to evaluate the quality of online content before giving recommendations to their patients. Physicians who use blogs, Twitter, and other outlets to vent against patients are “disrespectful” and may “undermine trust in the profession.”
The paper also discusses the problem of confidentiality in the digital age and maintaining security on mobile devices.
The authors recommend that physicians maintain clear and distinct professional and social identities online, but professional standards must be maintained in both spheres. Patients should not be “friended” by physicians and should not be included in the personal or social online interactions of physicians. The authors also advise physicians and physicians-in-training that medical humor, though intended for fellow professionals, can easily find a wider audience on the internet.
Categories: General
Tags: American College of Physicians, online behavior, professionalism, social media
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
Search the Archive
Archives by Date
NEJM — Recent Cardiology Articles- Managing Asymptomatic Carotid Stenosis January 15, 2026The management of carotid-artery stenosis that has not caused recent symptoms — asymptomatic carotid stenosis — has been controversial. Clinical trials that began more than 30 years ago showed a small benefit of carotid endarterectomy as compared with medical treatment, but improvements in medical prevention of stroke call into question...
- Sudden Cardiac Arrest in Athletes January 15, 2026Sudden cardiac arrest in athletes may be attributable to cardiac and noncardiac causes. With diagnosis and treatment, a return to play may be reasonable. Prevention, emergency planning, and shared decision making are key.
- Medical Management and Revascularization for Asymptomatic Carotid Stenosis January 15, 2026In high-grade asymptomatic carotid stenosis, addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit.
- Fish Oil for Patients Receiving Hemodialysis — Red Herring or Great Catch? January 8, 2026More than 470,000 patients with kidney failure receive hemodialysis in the United States alone, with worldwide estimates approaching 3 million patients. Mortality from kidney failure remains unacceptably high, with recent U.S. estimates of approximately 18% per year — higher than the mortality observed among patients with heart failure, diabetes, or...
- VESALIUS and the Anatomy of High-Risk Prevention January 8, 2026In the 16th century, the Flemish physician and anatomist Andreas Vesalius fundamentally advanced our understanding of the structure and function of the human body, providing particular insight on the inner workings of the circulatory system.1 The results of the VESALIUS-CV (Effect of Evolocumab in Patients at High Cardiovascular...
- Managing Asymptomatic Carotid Stenosis January 15, 2026
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
